학술논문
Discovery of ((4R,5S)-5-amino-4-(2,4,5-trifluorophenyl)cyclohex-1-enyl)-3- (trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Document Type
Article
Author
Pei, Z.; Li, X.; Von Geldern, T.W.; Madar, D.J.; Longenecker, K.; Yong, H.; Lubben, T.H.; Stewart, K.D.; Zinker, B.A.; Backes, B.J.; Judd, A.S.; Mulhern, M.; Ballaron, S.J.; Stashko, M.A.; Mika, A.K.; Beno, D.W.A.; Reinhart, G.A.; Fryer, R.M.; Preusser, L.C.; Kempf-Grote, A.J.; Sham, H.L.; Trevillyan, J.M.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 2 November 2006, 49(22):6439-6442)
Subject
Language
English
ISSN
00222623